Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Identification of cellular ion channels that facilitate Hazara nairovirus infection enables selection of clinically approved compounds with anti-nairoviral properties
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 24 March 2026

Identification of cellular ion channels that facilitate Hazara nairovirus infection enables selection of clinically approved compounds with anti-nairoviral properties

  • Frank W. Charlton1,2 nAff3,
  • Samantha E. Hover1,2,
  • Aseel Alyahyawi1,2,
  • Hayley M. Pearson1,2,
  • Thomas A. Edwards1,2 nAff4,
  • Jamel Mankouri1,2,
  • Martin Stacey1,
  • Juan Fontana1,2,5 &
  • …
  • John N. Barr1,2 

Scientific Reports , Article number:  (2026) Cite this article

  • 564 Accesses

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Drug discovery
  • Microbiology

Abstract

The Nairoviridae family of segmented negative-sense RNA viruses includes the serious human pathogen Crimean-Congo haemorrhagic fever virus (CCHFV), associated with a case/fatality rate of up to 40% for which no approved vaccines or treatments exist. Nairoviruses internalize via endocytosis and pass through the endolysosomal network, exploiting the changing ionic environment to promote envelope fusion. Fusion is influenced by hydrogen (H+) and potassium ions (K+), which increase in concentration as endosomes mature, regulated by host ion channels. Using the model nairovirus Hazara virus (HAZV) of the CCHFV serogroup, we performed an siRNA screen to identify cellular ion channels involved in nairovirus infection. Most high-ranking hits belonged to K+ and calcium (Ca2+) channel families. Consistent with this, we showed that clinically-approved K+ channel blockers quinidine, quinine and dronedarone and clinically-approved Ca2+ channel blockers tetrandrine and nifedipine significantly reduced HAZV activities. To further probe the role of K+ in HAZV infection, we used time-of-addition studies, showing K+ was required during entry. Biochemical experiments showed K+ expanded the pH range that promoted entry, potentially allowing endosome escape deeper within the endolysosomal network. These results show clinically-approved channel blockers effectively inhibit HAZV replication, suggesting repurposing existing therapies may represent promising avenues to block nairovirus infection.

Similar content being viewed by others

A single-dose mRNA vaccine protects mice from lethal Crimean-Congo hemorrhagic fever virus infection

Article Open access 12 December 2025

Synthesis, delivery, and molecular docking of fused quinolines as inhibitor of Hepatitis A virus 3C proteinase

Article Open access 23 September 2021

Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates

Article Open access 22 July 2021

Data availability

All data generated or analysed during this study are included in this published article (and its Supplementary Information files).

References

  1. Surtees, R. et al. The crystal structure of the Hazara virus nucleocapsid protein. BMC Struct. Biol. 15, 24 (2015).

    Google Scholar 

  2. Frank, M. G. et al. Crimean-Congo Hemorrhagic Fever Virus for clinicians-Diagnosis, clinical management, and therapeutics. Emerg. Infect. Dis. 30, 864–873 (2024).

    Google Scholar 

  3. Hawman, D. W. & Feldmann, H. Crimean–Congo haemorrhagic fever virus. Nat. Rev. Microbiol. 21, 463–477 (2023).

    Google Scholar 

  4. D’Addiego, J. et al. Investigating the effect of ribavirin treatment on genetic mutations in Crimean-Congo haemorrhagic fever virus (CCHFV) through next-generation sequencing. J. Med. Virol. 95, e28548 (2023).

    Google Scholar 

  5. Hawman, D. W. et al. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Res. 157, 18–26 (2018).

    Google Scholar 

  6. Oestereich, L. et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl. Trop. Dis. 8, e2804 (2014).

    Google Scholar 

  7. Fels, J. M. et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell 184, 3486-3501.e21 (2021).

    Google Scholar 

  8. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model - ScienceDirect. https://www.sciencedirect.com/science/article/pii/S0168170224001023.

  9. Sorvillo, T. E. et al. Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus. Npj Vaccines 9, 88 (2024).

    Google Scholar 

  10. Leventhal, S. S. et al. Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21. Nat. Commun. 15, 9236 (2024).

    Google Scholar 

  11. Dokuzoguz, B. et al. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin. Infect. Dis. 57, 1270–1274 (2013).

    Google Scholar 

  12. Punch, E. K. et al. Potassium is a trigger for conformational change in the fusion spike of an enveloped RNA virus. J. Biol. Chem. 293, 9937–9944 (2018).

    Google Scholar 

  13. Charlton, F. W. et al. Ion channels as therapeutic targets for viral infections: Further discoveries and future perspectives. Viruses 12, 844 (2020).

    Google Scholar 

  14. Scott, C. C. & Gruenberg, J. Ion flux and the function of endosomes and lysosomes: pH is just the start. BioEssays 33, 103–110 (2011).

    Google Scholar 

  15. Fuller, J. et al. Hazara nairovirus requires COPI components in both Arf1-dependent and Arf1-independent stages of its replication cycle. J. Virol. 94, e00766-e820 (2020).

    Google Scholar 

  16. Shaw, A. B. et al. Cellular endosomal potassium ion flux regulates arenavirus uncoating during virus entry. MBio 15, e01684 (2024).

    Google Scholar 

  17. Wang, B. et al. Dihydropyridine-derived calcium channel blocker as a promising anti-hantavirus entry inhibitor. Front. Pharmacol. 13, 940178 (2022).

    Google Scholar 

  18. Urata, S., Yoshikawa, R. & Yasuda, J. Calcium influx regulates the replication of several negative-strand RNA viruses including severe fever with thrombocytopenia syndrome virus. J. Virol. 97, e0001523 (2023).

    Google Scholar 

  19. Wang, G. & Lemos, J. R. Tetrandrine: A new ligand to block voltage-dependent Ca2+ and Ca(+)-activated K+ channels. Life Sci. 56, 295–306 (1995).

    Google Scholar 

  20. Dobson, S. J., Mankouri, J. & Whitehouse, A. Identification of potassium and calcium channel inhibitors as modulators of polyomavirus endosomal trafficking. Antiviral Res. https://doi.org/10.1016/j.antiviral.2020.104819 (2020).

    Google Scholar 

  21. Shekhar, S., Gupta, N., Kirubakaran, R. & Pareek, P. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: A systematic review and meta-analysis. BJOG Int. J. Obstet. Gynaecol. 123, 40–47 (2016).

    Google Scholar 

  22. Sherman, L. G. & Liang, C. S. Nifedipine in chronic stable angina: A double-blind placebo-controlled crossover trial. Am. J. Cardiol. 51, 706–711 (1983).

    Google Scholar 

  23. Patel, P. & Goyal, A. Antiarrhythmic Medications. in StatPearls (StatPearls Publishing, Treasure Island (FL), 2025).

  24. Armstrong, C. M. Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons. J. Gen. Physiol. 58, 413–437 (1971).

    Google Scholar 

  25. Fatherazi, S. & Cook, D. L. Specificity of tetraethylammonium and quinine for three K channels in insulin-secreting cells. J. Membr. Biol. 120, 105–114 (1991).

    Google Scholar 

  26. Revenko, S. V., Khodorov, B. I. & Shapovalova, L. M. [Blockade of the sodium and potassium channels of a myelinated nerve fiber by quinidine]. Neirofiziologiia Neurophysiol. 14, 324–330 (1982).

    Google Scholar 

  27. Hover, S. et al. Modulation of potassium channels inhibits bunyavirus infection. J. Biol. Chem. 291, 3411–3422 (2016).

    Google Scholar 

  28. Liu, P. et al. A tris (2-carboxyethyl) phosphine (TCEP) related cleavage on cysteine-containing proteins. J. Am. Soc. Mass Spectrom. 21, 837–844 (2010).

    Google Scholar 

  29. Helenius, A., Marsh, M. & White, J. Inhibition of Semliki Forest Virus penetration by lysosomotropic weak bases. J. Gen. Virol. 58, 47–61 (1982).

    Google Scholar 

  30. Schmidt, C. et al. Novel electrophysiological properties of dronedarone: Inhibition of human cardiac two-pore-domain potassium (K2P) channels. Naunyn-Schmiedeberg’s Arch. Pharmacol. 385, 1003–1016 (2012).

    Google Scholar 

  31. Thomas, D. et al. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels. Br. J. Pharmacol. 140, 996 (2003).

    Google Scholar 

  32. Hover, S. et al. Bunyavirus requirement for endosomal K+ reveals new roles of cellular ion channels during infection. PLoS Pathog. 14, e1006845 (2018).

    Google Scholar 

  33. Hover, S. et al. Organisation of the orthobunyavirus tripodal spike and the structural changes induced by low pH and K+ during entry. Nat. Commun. 14, 5885 (2023).

    Google Scholar 

  34. Simon, M., Johansson, C. & Mirazimi, A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 90, 210–215 (2009).

    Google Scholar 

  35. Jin, M. et al. Hantaan Virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 294, 60–69 (2002).

    Google Scholar 

  36. Koch, J. et al. The Phenuivirus Toscana virus makes an atypical use of vacuolar acidity to enter host cells. PLoS Pathog. 19, e1011562 (2023).

    Google Scholar 

  37. Bowden, T. A. et al. Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike. PLoS Pathog. 9, e1003374 (2013).

    Google Scholar 

  38. Hover, S., Foster, B., Barr, J. N. & Mankouri, J. Viral dependence on cellular ion channels – An emerging anti-viral target?. J. Gen. Virol. 98, 345–351 (2017).

    Google Scholar 

  39. Russell, T., Gangotia, D. & Barry, G. Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication. Biomed. Pharmacother. Biomedecine Pharmacother. 156, 113850 (2022).

    Google Scholar 

  40. Vitali Serdoz, L., Rittger, H., Furlanello, F. & Bastian, D. Quinidine-A legacy within the modern era of antiarrhythmic therapy. Pharmacol. Res. 144, 257–263 (2019).

    Google Scholar 

  41. Fuller, J. et al. Rescue of infectious recombinant Hazara Nairovirus from cDNA reveals the nucleocapsid protein DQVD caspase cleavage motif performs an essential role other than cleavage. J. Virol. https://doi.org/10.1128/jvi.00616-19 (2019).

    Google Scholar 

  42. Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).

    Google Scholar 

Download references

Acknowledgements

We acknowledge Wellcome trust equipment grant 221538/Z/20/Z, which supports the use of the IncuCyte live cell imaging platform.

Funding

This work was supported by a University of Leeds PhD studentship to FWC, MRC project Grant MR/T016159/1 to JNB, JF, JM and TAE, BBSRC project grant BB/V007467/1 to JNB, JM and HP, grant PID2023-149259NB-I00 funded by MICIU/AEI/ https://doi.org/10.13039/501100011033, a Human Frontiers Science Programme grant RGP0040/2019 awarded to JF, and by “ERDF A way of making Europe” to JF.

Author information

Author notes
  1. Frank W. Charlton

    Present address: Laboratory of Environmental Virology (LEV), l’École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

  2. Thomas A. Edwards

    Present address: College of Biomedical Sciences, Larkin University, 18301 N Miami Avenue, Miami, FL, 33169, USA

Authors and Affiliations

  1. School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK

    Frank W. Charlton, Samantha E. Hover, Aseel Alyahyawi, Hayley M. Pearson, Thomas A. Edwards, Jamel Mankouri, Martin Stacey, Juan Fontana & John N. Barr

  2. Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK

    Frank W. Charlton, Samantha E. Hover, Aseel Alyahyawi, Hayley M. Pearson, Thomas A. Edwards, Jamel Mankouri, Juan Fontana & John N. Barr

  3. Instituto Biofisika (IBF), CSIC-UPV/EHU, Barrio Sarriena s/n, 48940, Leioa, Spain

    Juan Fontana

Authors
  1. Frank W. Charlton
    View author publications

    Search author on:PubMed Google Scholar

  2. Samantha E. Hover
    View author publications

    Search author on:PubMed Google Scholar

  3. Aseel Alyahyawi
    View author publications

    Search author on:PubMed Google Scholar

  4. Hayley M. Pearson
    View author publications

    Search author on:PubMed Google Scholar

  5. Thomas A. Edwards
    View author publications

    Search author on:PubMed Google Scholar

  6. Jamel Mankouri
    View author publications

    Search author on:PubMed Google Scholar

  7. Martin Stacey
    View author publications

    Search author on:PubMed Google Scholar

  8. Juan Fontana
    View author publications

    Search author on:PubMed Google Scholar

  9. John N. Barr
    View author publications

    Search author on:PubMed Google Scholar

Contributions

FWC, HMP, SEH and AA acquired the data. FWC, MS, JF and JNB analysed and interpreted the data. TAE and JM made contributions to the conception and design of the work. FWC, JF and JNB wrote the manuscript. FWC made the figures. All authors approved the submitted version of the manuscript.

Corresponding authors

Correspondence to Juan Fontana or John N. Barr.

Ethics declarations

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Supplementary Information 1. (download XLSX )

Supplementary Information 2. (download XLSX )

Supplementary Information 3. (download PDF )

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Charlton, F.W., Hover, S.E., Alyahyawi, A. et al. Identification of cellular ion channels that facilitate Hazara nairovirus infection enables selection of clinically approved compounds with anti-nairoviral properties. Sci Rep (2026). https://doi.org/10.1038/s41598-026-42810-7

Download citation

  • Received: 11 September 2025

  • Accepted: 27 February 2026

  • Published: 24 March 2026

  • DOI: https://doi.org/10.1038/s41598-026-42810-7

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research